Does TAFASITAMAB-CXIX Cause Disease progression? 218 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 218 reports of Disease progression have been filed in association with TAFASITAMAB-CXIX. This represents 29.6% of all adverse event reports for TAFASITAMAB-CXIX.
218
Reports of Disease progression with TAFASITAMAB-CXIX
29.6%
of all TAFASITAMAB-CXIX reports
41
Deaths
8
Hospitalizations
How Dangerous Is Disease progression From TAFASITAMAB-CXIX?
Of the 218 reports, 41 (18.8%) resulted in death, 8 (3.7%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB-CXIX. However, 218 reports have been filed with the FAERS database.
What Other Side Effects Does TAFASITAMAB-CXIX Cause?
Lymphoma (158)
Off label use (126)
Death (53)
Drug ineffective (39)
Blood lactate dehydrogenase increased (34)
Diffuse large b-cell lymphoma (32)
Malignant neoplasm progression (30)
Neutropenia (30)
Polyneuropathy (29)
Covid-19 (28)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TAFASITAMAB-CXIX Alternatives Have Lower Disease progression Risk?
TAFASITAMAB-CXIX vs TAFINLAR
TAFASITAMAB-CXIX vs TAFLUPROST
TAFASITAMAB-CXIX vs TAGRAXOFUSP-ERZS
TAFASITAMAB-CXIX vs TAHOR
TAFASITAMAB-CXIX vs TALAZOPARIB